Abiopharma

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001839882-26-019373 <b>Size:</b> 760 KB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001839882-26-019372 <b>Size:</b> 266 KB

New Form SCHEDULE 13G/A - BNY Mellon Municipal Bond Infrastructure Fund, Inc. <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001445546-26-002473 <b>Size:</b> 15 KB

📋 Darwish Mohamad (EVP, IHS Nigeria Chief Executive Officer) plans to sell 28K shares of IHS Holding Ltd (at $8.31 each, total $233K) Filed: Apr 07, 2026 | ID: 000140

New Form SCHEDULE 13G/A - abrdn Income Credit Strategies Fund <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001445546-26-002471 <b>Size:</b> 15 KB

Xu Jiayuan 🟡 adjusted position in 214.2K shares (2 derivative) of FinVolution Group (FINV) Transaction Date: Apr 03, 2026 | Filing ID: 015435

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of interest/ Changes in interest of Directors/ Chief Executive Officer

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

(50% Neutral) ARTELO BIOSCIENCES, INC. (ARTL) Announces Clinical Development Update

(10% Negative) CUE BIOPHARMA, INC. (CUE) Announces Business Combination